Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow Quality Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Quality Index of 1.37x as of September 2025. Operating cash flow of ₩4.70 Billion exceeds net income of ₩3.42 Billion, indicating high earnings quality where cash backs reported profits. Explore Sinsin Pharmaceutical Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sinsin Pharmaceutical Co. Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sinsin Pharmaceutical Co. Ltd (002800) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year earnings quality comparison for Sinsin Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see Sinsin Pharmaceutical Co. Ltd market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.24x | ₩5.94 Billion | ₩4.81 Billion | ▲ +46.0% |
| 2023 | 0.85x | ₩3.93 Billion | ₩4.65 Billion | ▼ -31.6% |
| 2022 | 1.24x | ₩5.46 Billion | ₩4.41 Billion | ▼ -75.9% |
| 2020 | 5.14x | ₩1.87 Billion | ₩362.66 Million | ▲ +344.0% |
| 2019 | -2.11x | ₩-4.51 Billion | ₩2.14 Billion | ▼ -888.4% |
| 2018 | 0.27x | ₩774.24 Million | ₩2.90 Billion | ▼ -78.9% |
| 2017 | 1.27x | ₩4.57 Billion | ₩3.60 Billion | ▲ +101.4% |
| 2016 | 0.63x | ₩2.79 Billion | ₩4.44 Billion | ▼ -53.3% |
| 2015 | 1.35x | ₩5.24 Billion | ₩3.89 Billion | — |